方案
≥97% (SDS-PAGE)
质量水平
表单
lyophilized
制造商/商品名称
Calbiochem®
储存条件
OK to freeze
avoid repeated freeze/thaw cycles
杂质
≤1 EU/μg Endotoxin (EU/ug of TGF-β1)
运输
ambient
储存温度
−20°C
一般描述
Native transforming growth factor-β1 from human platelets. Promotes apoptosis in resting human B lymphocytes, glioma cells, and trigeminal neurinomal cells.
Native transforming growth factor-β1 from human platelets. Promotes apoptosis in resting human B lymphocytes, glioma cells, and trigerminal neurinomal cells.
生化/生理作用
ED₅₀ = 40-10 pg/ml as measured by the inhibition of IL-4-dependant proliferation of mouse HT-2 cells using resazurin dye as an indicator of cell proliferation.
外形
Lyophilized from a sterile-filtered solution of 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA.
制备说明
Following reconstitution, store in the refrigerator (4°C) for short-term storage or freeze (-20°C) for long-term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 months at 4°C or up to 3 months at -20°C..
Prepared from blood that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Reconstitute to a concentration ≥10 µg/ml in sterile 4 mM HCl containing ≥0.1% HSA or BSA.
其他说明
Lomo, J., et al. 1995. J. Immunol.154, 1634.
Marushige, K. and Marushige, Y. 1995. Anticancer Res.14, 2419.
Bermundez, L.E. 1993. J. Immunol.150, 1838.
Hamilton, J.A., et al. 1993. J. Immunol.150, 1496.
Reilly, J.T., et al. 1993. Br. J. Haematol.83, 58.
Sporn, M.B. and Roberts, A.B. 1993. Growth Factors8, 1.
Marushige, K. and Marushige, Y. 1995. Anticancer Res.14, 2419.
Bermundez, L.E. 1993. J. Immunol.150, 1838.
Hamilton, J.A., et al. 1993. J. Immunol.150, 1496.
Reilly, J.T., et al. 1993. Br. J. Haematol.83, 58.
Sporn, M.B. and Roberts, A.B. 1993. Growth Factors8, 1.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
Toxicity: Standard Handling (A)
储存分类代码
11 - Combustible Solids
WGK
WGK 3
法规信息
新产品
此项目有
Hui Zhao et al.
Molecular cancer therapeutics, 11(2), 503-513 (2011-12-14)
A growing body of data indicates that inhibiting the type 1 insulin-like growth factor receptor (IGF-1R) might be an effective treatment strategy for hepatocellular carcinoma (HCC). OSI-906 is a dual IGF-1R/IR kinase inhibitor currently in phase II clinical development for
Uyen Q Le et al.
Scientific reports, 12(1), 19504-19504 (2022-11-15)
Triple negative breast cancer (TNBC) is a disease of poor prognosis, with the majority classified as the basal-like subtype associated with epithelial-mesenchymal transition and metastasis. Because basal breast cancers originate from proliferative luminal progenitor-like cells upon dysregulation of proper luminal
Gretchen M Argast et al.
Cells, tissues, organs, 193(1-2), 114-132 (2010-11-03)
Epithelial to mesenchymal transition (EMT) plays a dual role in tumor progression. It enhances metastasis of tumor cells by increasing invasive capacity and promoting survival, and it decreases tumor cell sensitivity to epithelial cell-targeting agents such as epithelial growth factor
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持